Register for Upcoming Webinar on DEC. 8 @ 11AM
2025 China NMPA Bluebook is here:
The global application of molecular diagnostics has gradually evolved from the initial diagnosis of infectious diseases to the current personalized treatment and genetic disease screening,
According to the statistics of China Blueprint for In Vitro Diagnostic, as of 2016, the size of China’s immunodiagnostic market reached 16.2 billion RMB (2.61
Due to the impact of the birth control policy and the decline in birth rate after the economy growth, the population structure in China is
Grace Palma, CEO of China Med Device On my flight to China, my seat mate is a Harvard Medical School professor specializing in stem cell research.
Grace Palma, CEO of China Med Device On my flight to China, my seat mate is a Harvard Medical School professor specializing in stem cell research.
China National Cancer Center released the latest national report on the incidence and mortality rate of cancer on April 6. It is estimated that there
May 2, 2018 2-3 PM EST Registration is Closed China has become the 2nd largest med-tech market in the world. Chinese government plans to
Severe cardiac arrhythmia is the leading cause of sudden cardiac death, and radiofrequency ablation is an important means of non-drug treatment of arrhythmia. During the
According to the statistics cited in the 2015 China Cardiovascular Diseases (CVD) report, the number of cardiovascular patients in China has reached 290 million. That
Esaote, Italian-based medical equipment company with a focus on ultrasound, magnetic resonance imaging and diagnostic management software, was acquired by consortium of fund from China
The public Chinese healthcare system is getting overcrowded. Medical resources are getting stretched thin. This is particularly evident in level III public hospitals. The government,
China Med Device, LLC, specializing in CFDA registration/CRO and commercialization services for western medical devices and IVDs, is exhibiting at CMEF, the largest medical device